DDX20 Protein
Overview
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">DDX20 Protein</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>DDX20</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>DDX20</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Protein</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/?query=DDX20" target="_blank">Search UniProt</a></td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">9 edges</a></td>
</tr>
</table>
DDX20 (also known as Gemin3) is a DEAD-box RNA helicase that plays critical roles in RNA processing and is implicated in neurodegenerative diseases. [@charroux2010] This protein functions as an essential component of the SMN complex, where it facilitates spliceosome biogenesis and snRNP assembly. Research has demonstrated its importance in maintaining neuronal health and its potential involvement in conditions such as amyotrophic lateral sclerosis and spinal muscular atrophy. [@auto_14699164][@auto_37894677]
Structure
Background
ATP7A is a copper-transporting P-type ATPase that plays essential roles in copper homeostasis. For detailed information about its structure, function, and role in disease, refer to the main sections of this article.
Domain Architecture
...DDX20 Protein
Overview
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">DDX20 Protein</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>DDX20</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>DDX20</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Protein</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/?query=DDX20" target="_blank">Search UniProt</a></td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">9 edges</a></td>
</tr>
</table>
DDX20 (also known as Gemin3) is a DEAD-box RNA helicase that plays critical roles in RNA processing and is implicated in neurodegenerative diseases. [@charroux2010] This protein functions as an essential component of the SMN complex, where it facilitates spliceosome biogenesis and snRNP assembly. Research has demonstrated its importance in maintaining neuronal health and its potential involvement in conditions such as amyotrophic lateral sclerosis and spinal muscular atrophy. [@auto_14699164][@auto_37894677]
Structure
Background
ATP7A is a copper-transporting P-type ATPase that plays essential roles in copper homeostasis. For detailed information about its structure, function, and role in disease, refer to the main sections of this article.
Domain Architecture
The DDX20 protein possesses a distinctive domain architecture consisting of an N-terminal domain featuring multiple repeats, two RecA-like helicase domains that form the core helicase region, and a C-terminal domain. The protein contains nine conserved motifs characteristic of DEAD-box helicases, which are essential for its catalytic activity. [@auto_14699164]
Structural Features
Key structural features of DDX20 include an ATP-binding motif (Walker A), an ATP-hydrolysis motif (Walker B), and the characteristic DEAD box sequence motif (Asp-Glu-Ala-Asp). The flexible C-terminal tail facilitates protein interactions with various cellular partners. DDX20 forms complexes with other SMN complex proteins, enabling its participation in large macromolecular assemblies necessary for spliceosome function.
Normal Function
RNA Helicase Activity
DDX20 functions as an ATP-dependent RNA helicase capable of unwinding short RNA duplexes of 20-25 base pairs without requiring the unwinding of longer duplex structures. The protein utilizes ATP hydrolysis to drive conformational changes that enable its catalytic activity. This helicase function allows DDX20 to modulate both RNA-RNA and RNA-protein interactions within the cell, thereby influencing various aspects of RNA metabolism. [@auto_14699164]
SMN Complex Function
DDX20 serves as an essential component of the SMN complex, where it plays a critical role in snRNP (small nuclear ribonucleoprotein) assembly and spliceosome biogenesis. The protein facilitates the assembly of the heptameric Sm rings on snRNA molecules, a process fundamental to spliceosome formation. Additionally, DDX20 participates in the regeneration of snRNPs, ensuring the continuous availability of these complexes for pre-mRNA splicing. [@auto_37894677]
Transcriptional Regulation
DDX20 associates with the Sin3A histone deacetylase complex and acts as a transcriptional co-repressor in various cellular contexts. Through this association, the protein modulates the activity of numerous transcription factors and regulates p53-mediated transcription. These transcriptional regulatory functions expand the biological roles of DDX20 beyond its classical RNA helicase activities.
RNA Processing
Beyond its helicase function, DDX20 participates in multiple aspects of RNA processing. The protein functions in pre-mRNA splicing, where it affects alternative splicing patterns that can influence gene expression outcomes. DDX20 is also involved in RNA transport and ribosome biogenesis, highlighting its versatility in RNA metabolism. [@auto_37894677]
Role in Disease
Amyotrophic Lateral Sclerosis (ALS)
DDX20 is implicated in ALS pathogenesis through multiple mechanisms involving SMN complex dysfunction. The SMN complex function is altered in ALS, leading to dysregulation of snRNP assembly that contributes to RNA processing defects observed in the disease. DDX20 interacts with several ALS-related proteins including FUS and SMN, suggesting it may be part of broader pathological networks affecting motor neurons. Motor neurons are particularly vulnerable to DDX20 dysfunction due to their high dependence on proper RNA processing and spliceosome function. [@auto_14699164]
Spinal Muscular Atrophy (SMA)
The SMN complex is deficient in SMA, and DDX20 plays an essential role in maintaining SMN complex function under these conditions. snRNP assembly is impaired in SMA, contributing to the cellular deficits that underlie the disease phenotype. Therapeutic strategies targeting SMN expression or function may improve DDX20 function indirectly, as both proteins depend on the integrity of the SMN complex for their proper operation. [@auto_14699164]
Cancer
In certain cellular contexts, DDX20 acts as a tumor suppressor, regulating p53-dependent apoptosis to prevent uncontrolled cell proliferation. The protein shows altered expression in various cancers, making it potentially useful as a prognostic marker in certain malignancy types. DDX20 protein stability is regulated by DAPK through suppression of TRIM25-mediated ubiquitination, providing an important regulatory mechanism that can be disrupted in cancer cells. [@auto_39558224]
Therapeutic Targeting
Current Status
DDX20 is not currently a direct therapeutic target in clinical practice, but understanding its role in SMN complex function may inform SMA therapies under development. Research is ongoing to better understand DDX20's role in neurodegeneration, with particular focus on how SMN complex deficits affect DDX20 localization and function in motor neurons.
Research Directions
Several promising research directions are being pursued, including the development of DDX20 activity modulators that could potentially enhance residual protein function in disease states. Scientists are working to understand the protein-protein interactions that govern DDX20 localization and activity within the cell. Additionally, researchers are exploring the potential utility of DDX20 as a biomarker for disease progression or therapeutic response in neurodegenerative conditions.
Key Publications
[Mourelatos et al., Gemin3 defines a novel nuclear protein complex (2002)](https://doi.org/10.1016/S1097-2765(02)00592-8)
[Liu et al., Structural basis for DDX20 function (2014)](https://doi.org/10.1016/j.jmb.2014.05.019)
[Burchell et al., DDX20 in cancer and p53 signaling (2013)](https://doi.org/10.1038/onc.2012.566)Cross-References
- [DDX20 Gene](/genes/ddx20)
- [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
- [Spinal Muscular Atrophy](/diseases/spinal-muscular-atrophy)
- [SMN1 Protein](/proteins/smn1-protein)
- [FUS Protein](/proteins/fus-protein)
- [RNA Splicing Pathway](/mechanisms/rna-splicing)
External Links
- [NCBI Gene](https://www.ncbi.nlm.nih.gov/gene/)
- [UniProt](https://www.uniprot.org/)
References
[Charroux B, et al, DDX20 in neuronal function (2010)](https://pubmed.ncbi.nlm.nih.gov/21068313/)